8 results
IDSA Recommendations for empirical antimicrobial therapy for purulent meningitis based on patient age and specific predisposing
Recommendations for empirical ... IDSA #Meningitis #Antibiotics ... #Coverage #InfectiousDiseases ... #Pharmacology # ... Management
â–º
Table 3. Suggested Empiric Treatment Options for Clinically Suspected Ventilator-Associated Pneumonia in Units Where Empiric Methicillin-Resistant
Suggested Empiric ... Antipseudomonal/Gram-Negative ... Are Appropriate #Management ... #InfectiousDiseases ... #Empiric #Antibiotics
Antibiotics for Intraabdominal Infection. 
Use your local antimicrobial susceptibility data for selecting the best empiric treatment!
Antibiotics for ... selecting the best empiric ... #antibiogram #antibiotics ... antimicrobials #infectiousdiseases ... #management #pharmacology
Coverage of common antibiotics used in the hospital

For empiric coverage, first define the type of infection,
hospital For empiric ... ampicillin #management ... #infectiousdisease ... #antibiotics ... #antibiogram #pharmacology
CAPD-associated peritonitis (Continuous Ambulatory Peritoneal Dialysis) - 5 Things To Know
Diagnosis (Two of the following):
(1) Clinical
• 15-35% Gram negative ... Treatment • Empiric ... • Prophylactic antibiotics ... peritonitis #Diagnosis #Management ... #InfectiousDiseases
Intern Pocket Cards - Antibiogram and Susceptibilities
VRE - MRSA - GRAM POSITIVES - GRAM NEGATIVES -
Intern Pocket Cards ... POSITIVES - GRAM NEGATIVES ... Inpatient Pocket Cards ... Susceptibilities #antibiotics ... #management #pharmacology
In ARDS, we know that the lungs are so diffusely injured that the remaining total area
In ARDS, we know ... with regions of relative ... #pathophysiology ... #diagnosis #management ... #ards #foamed #
Anti-Pseudomonal - Antibiotics Class Overview

Pseudomonas aeruginosa is a non-fermenting Gram-negative bacillus that inhabits a variety of
Anti-Pseudomonal - Antibiotics ... non-fermenting Gram-negative ... It is feared due ... monotherapy for empiric ... Polymyxin B(IV) #Pharmacology